FBO#5415
A - Research and Development
FEDBIZOPPS: AWARDS - September 20, 2016
- HHSO100201600014C - $9,467,928
DEVELOPMENT OF POINT-OF-CARE AND LABORATORY-BASED IMMUNOASSAYS FOR PRESUMPTIVE DIAGNOSIS OF ZIKA VIRUS INFECTION
InBios International, Inc., 562 1st Avenue South, Suite 600, Seattle, Washington 98104-3829, United States
- HHSO100201600002C - $100,103,644
CLINICAL DEVELOPMENT OF CEFTOBIPROLE
Basilea Pharmaceutica International Ltd., Grenzacherstrasse 487<br />, Basel, Switzerland, Non-U.S., United States
- HHSO100201600008C - $120,275,880
DEVELOPMENT OF A SINGLE DOSE INTRANASAL POST-EXPOSURE PROPHYLAXIS VACCINE FOR INHALATION ANTHRAX
Altimmune, Inc., 19 Firstfield Road, Suite 200, Gaithersburg, Maryland 20878-1791, United States
| This Issue's Index | Today's FBO Daily Index Page |
Created on 18-Sep-2016 by Loren Data Corp. -- info@fbodaily.com